Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)
Clinical trial NCT04938752 · COMPLETED
Trial details
- NCT number
- NCT04938752
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2021-08-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.